| Overexpression of the microRNA miR‐433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells K Weiner‐Gorzel, E Dempsey, M Milewska, A McGoldrick, V Toh, A Walsh, ... Cancer medicine 4 (5), 745-758, 2015 | 176 | 2015 |
| Complement in tumourigenesis and the response to cancer therapy RM O’Brien, A Cannon, JV Reynolds, J Lysaght, N Lynam-Lennon Cancers 13 (6), 1209, 2021 | 25 | 2021 |
| Pyrazinib (P3),[(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma AM Buckley, MR Dunne, N Lynam-Lennon, SA Kennedy, A Cannon, ... Cancer letters 447, 115-129, 2019 | 22 | 2019 |
| Parallel profiles of inflammatory and effector memory T cells in visceral fat and liver of obesity-associated cancer patients MJ Conroy, KC Galvin, SL Doyle, ME Kavanagh, AM Mongan, A Cannon, ... Inflammation 39, 1729-1736, 2016 | 18 | 2016 |
| Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti-inflammatory molecule PH46A K Chan, N Frankish, T Zhang, A Ece, A Cannon, J O'Sullivan, H Sheridan Journal of Pharmacy and Pharmacology 72 (7), 927-937, 2020 | 17 | 2020 |
| Visceral adipose tissue modulates radiosensitivity in oesophageal adenocarcinoma AM Mongan, N Lynam-Lennon, SL Doyle, R Casey, E Carr, A Cannon, ... International Journal of Medical Sciences 16 (4), 519, 2019 | 16 | 2019 |
| Therapeutic potential of PARP inhibitors in the treatment of gastrointestinal cancers A Alhusaini, A Cannon, SG Maher, JV Reynolds, N Lynam-Lennon Biomedicines 9 (8), 1024, 2021 | 15 | 2021 |
| The protein secretome is altered in rectal cancer tissue compared to normal rectal tissue, and alterations in the secretome induce enhanced innate immune responses AB Heeran, MR Dunne, ME Morrissey, CE Buckley, N Clarke, A Cannon, ... Cancers 13 (3), 571, 2021 | 11 | 2021 |
| Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells. Cancer Med 2015; 4 (5): 745-58 K Weiner-Gorzel, E Dempsey, M Milewska, A McGoldrick, V Toh, A Walsh, ... DOI: https://doi. org/10.1002/cam4 409, 745-758, 0 | 11 | |
| Examining the connectivity between different cellular processes in the Barrett tissue microenvironment JJ Phelan, R Feighery, OS Eldin, SO Meachair, A Cannon, R Byrne, ... Cancer Letters 371 (2), 334-346, 2016 | 7 | 2016 |
| (E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma. Cancer Lett. 2019; 447: 115–129. doi: 10.1016 … AM Buckley, MR Dunne, N Lynam-Lennon, SA Kennedy, A Cannon, ... CrossRef][Google Scholar], 0 | 7 | |
| Trends in addiction treatment in Irish prisons using national surveillance data, 2009–2014 A Cannon, F Nally, A Collins, R Fay, S Lyons International Journal of Prisoner Health 15 (2), 105-113, 2019 | 3 | 2019 |
| The protein secretome is altered in rectal cancer tissue compared to normal rectal tissue, and alterations in the secretome induce enhanced innate immune responses 2021; 13 (3 … AB Heeran, MR Dunne, ME Morrissey, CE Buckley, N Clarke, A Cannon, ... DOI: https://doi. org/10.3390/cancers13 30571, 2021 | 2 | 2021 |
| Effect of cigarette smoke extract on the intestinal microenvironment of ulcerative colitis tissue A Cannon, N Clarke, F MacCarthy, C Dunne, D Kevans, N Mahmud, ... JGH Open 4 (6), 1191-1198, 2020 | 2 | 2020 |
| Investigating the role of the complement system in the radioresistance of rectal cancer R O'Brien, C Buckley, A Cannon, S Meltzer, KR Redalen, J Lysaght, ... MOLECULAR IMMUNOLOGY 141, 194-194, 2022 | 1 | 2022 |
| A Novel Role for the Complement Cascade in Chemoradiation Therapy Resistant Oesophageal Adenocarcinoma A Cannon, D Lavin, R Byrne, RM Santiago, JV Reynolds, J O'Sullivan, ... MOLECULAR IMMUNOLOGY 114, 475-475, 2019 | 1 | 2019 |
| Generation and Characterization of an Isogenic Cell Line Model of Radioresistant Esophageal Adenocarcinoma A Cannon, SG Maher, N Lynam-Lennon Cancer Cell Culture: Methods and Protocols, 139-152, 2023 | | 2023 |
| A novel role for the complement cascade in chemoradiation therapy resistant oesophageal adenocarcinoma A Cannon, RM Santiago, D Lavin, R Byrne, JV Reynolds, J O'Sullivan, ... MOLECULAR IMMUNOLOGY 141, 120-121, 2022 | | 2022 |
| Complement in Tumourigenesis and the Response to Cancer Therapy. Cancers 2021, 13, 1209 RM O’Brien, A Cannon, JV Reynolds, J Lysaght, N Lynam-Lennon s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| RA10. 02: A NOVEL ROLE FOR THE COMPLEMENT CASCADE IN CHEMORADIATION THERAPY RESISTANT OESOPHAGEAL ADENOCARCINOMA. A Cannon, D Lavin, R Byrne, J Reynolds, J O'Sullivan, N Lynam-Lennon Diseases of the Esophagus 31 (13), 2018 | | 2018 |
